Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time

被引:23
|
作者
Rodebaugh, Thomas L. [1 ]
Frumkin, Madelyn R. [1 ]
Reiersen, Angela M. [2 ]
Lenze, Eric J. [2 ]
Avidan, Michael S. [3 ]
Miller, J. Philip [4 ]
Piccirillo, Jay F. [5 ]
Zorumski, Charles F. [2 ]
Mattar, Caline [6 ]
机构
[1] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO 63130 USA
[2] Washington Univ Sch Med WUSM, Dept Psychiat, St Louis, MO USA
[3] WUSM, Dept Anesthesiol, St Louis, MO USA
[4] WUSM, Div Biostat, Inst Informat, St Louis, MO USA
[5] WUSM, Dept Otolaryngol, St Louis, MO USA
[6] WUSM, Div Infect Dis, Dept Internal Med, St Louis, MO USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2021年 / 8卷 / 03期
基金
美国国家卫生研究院;
关键词
cough; COVID-19; humans; severe acute respiratory syndrome coronavirus 2; smell; taste;
D O I
10.1093/ofid/ofab090
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The symptoms of coronavirus disease 2019 (COVID-19) appear to be heterogenous, and the typical course of these symptoms is unknown. Our objectives were to characterize the common trajectories of COVID-19 symptoms and to assess how symptom course predicts other symptom changes as well as clinical deterioration. Methods. One hundred sixty-two participants with acute COVID-19 responded to surveys up to 31 times for up to 17 days. Several statistical methods were used to characterize the temporal dynamics of these symptoms. Because 9 participants showed clinical deterioration, we explored whether these participants showed any differences in symptom profiles. Results. Trajectories varied greatly between individuals, with many having persistently severe symptoms or developing new symptoms several days after being diagnosed. A typical trajectory was for a symptom to improve at a decremental rate, with most symptoms still persisting to some degree at the end of the reporting period. The pattern of symptoms over time suggested a fluctuating course for many patients. Participants who showed clinical deterioration were more likely to present with higher reports of severity of cough and diarrhea. Conclusions. The course of symptoms during the initial weeks of COVID-19 is highly heterogeneous and is neither predictable nor easily characterized using typical survey methods. This has implications for clinical care and early-treatment clinical trials. Additional research is needed to determine whether the decelerating improvement pattern seen in our data is related to the phenomenon of patients reporting long-term symptoms and whether higher symptoms of diarrhea in early illness presages deterioration.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Mild or Moderate Covid-19
    Gandhi, Rajesh T.
    Lynch, John B.
    del Rio, Carlos
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1757 - 1766
  • [2] Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series
    Brasil Matos, Aline de Moura
    Dahy, Flavia Esper
    Luisi de Moura, Joao Victor
    Nascimento Marcusso, Rosa Maria
    Ferreira Gomes, Andre Borges
    Maia Carvalho, Fernanda Martins
    Peres Fernandes, Gustavo Bruniera
    Felix, Alvina Clara
    Smid, Jerusa
    Vidal, Jose Ernesto
    Ferreira Frota, Norberto Anizio
    Casseb, Jorge
    Easton, Ava
    Solomon, Tom
    Witkin, Steven S.
    Romano, Camila Malta
    Penalva de Oliveira, Augusto Cesar
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [3] Quantitative plasma proteome profiling of COVID-19 patients with mild and moderate symptoms
    Jiang, He-Wei
    Tao, Sheng-Ce
    EBIOMEDICINE, 2022, 75
  • [4] The importance of early detection of ENT symptoms in mild-to-moderate COVID-19
    Spinato, Giacomo
    Costantini, Giulio
    Fabbris, Cristoforo
    Menegaldo, Anna
    Mularoni, Francesca
    Gaudioso, Piergiorgio
    Mantovani, Monica
    Borsetto, Daniele
    Vijendren, Ananth
    Da Mosto, Maria Cristina
    Boscolo-Rizzo, Paolo
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2021, 41 (02) : 101 - 107
  • [5] Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador
    Checa, Alejandro
    Navas, Eliana
    Valencia, Veronica
    Alcivar, Jessica
    REVISTA MEXICANA DE NEUROCIENCIA, 2022, 23 (04): : 126 - 129
  • [6] Post-COVID symptoms and recovery times in hospitalized mild and moderate COVID-19 patients
    Khot, Rajashree
    Patil, Aastha
    Rathod, Bharatsing
    Kumbhalkar, Sunita D.
    Joshi, Prashant P.
    INTERNATIONAL JOURNAL OF ACADEMIC MEDICINE, 2023, 9 (02) : 39 - 46
  • [7] Azithromycin for mild-to-moderate COVID-19
    Hinks, Timothy S. C.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : E100 - E101
  • [8] Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms
    Zhong, Wen
    Altay, Ozlem
    Arif, Muhammad
    Edfors, Fredrik
    Doganay, Levent
    Mardinoglu, Adil
    Uhlen, Mathias
    Fagerberg, Linn
    EBIOMEDICINE, 2021, 74
  • [9] Oral symptoms potentially associated with mild-to-moderate COVID-19 in tobacco users
    Alkharobi, Hanaa E.
    TOBACCO INDUCED DISEASES, 2024, 22
  • [10] Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19
    Kravchenko, Dmitrij
    Isaak, Alexander
    Zimmer, Sebastian
    Mesropyan, Narine
    Reinert, Matthaus
    Faron, Anton
    Pieper, Claus C.
    Heine, Annkristin
    Velten, Markus
    Nattermann, Jacob
    Kuetting, Daniel
    Duerr, Georg D.
    Attenberger, Ulrike, I
    Luetkens, Julian A.
    RADIOLOGY, 2021, 301 (03) : E419 - E425